The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated safety and efficacy results of SHR-1316 combined with chemotherapy and sequential chest radiotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC) from a phase II trial.
 
Dawei Chen
No Relationships to Disclose
 
Aiqin Gao
No Relationships to Disclose
 
Wei Huang
No Relationships to Disclose
 
Qian Shao
No Relationships to Disclose
 
Xiangjiao Meng
No Relationships to Disclose
 
Xiaoyong Tang
No Relationships to Disclose
 
Pinliang Zhang
No Relationships to Disclose
 
Xudong Hu
No Relationships to Disclose
 
Yan Zhang
No Relationships to Disclose
 
Jun Guo
No Relationships to Disclose
 
Lei Fu
No Relationships to Disclose
 
Wei Zhao
No Relationships to Disclose
 
Changhong Zhao
Employment - Jiangsu Hengrui Pharmaceuticals
 
Jiajia Yuan
Employment - Jiangsu Hengrui Pharmaceuticals
 
Jinming Yu
No Relationships to Disclose
 
Linlin Wang
No Relationships to Disclose